Abstract
Mean platelet (PLT) activation has an important role in the development of vascular diseases. In this study, we aimed to investigate the PLT volume in patients with vasculogenic and nonvasculogenic erectile dysfunction (ED) and compare it with the control group. Mean PLT volume (MPV) levels were measured in 50 patients with vasculogenic ED, in 30 patients who developed ED after radical prostatectomy (nonvasculogenic) and in 40 healthy controls. Ages were similar between the three groups. The diagnosis of ED was based on detailed sexual history, physical examination, laboratory assessment and color Doppler ultrasonography and is defined as the inability to attain or maintain a penile erection that is sufficient for successful vaginal intercourse. The results are given as mean±s.d. of the mean. The mean age of the patients with vasculogenic ED, of patients with ED after radical prostatectomy and of the control group were 53.70±12.39 (range 24–77), 54.60±11.40 (range 43–61) and 53.85±9.5 (range 30–73), respectively (P=0.853). The MPV and PLT values were significantly higher in patients with vasculogenic ED than in patients with ED after radical prostatectomy and in control groups: 7.49±1.4, 6.43±1.19 and 6.85±1.2 for MPV and 262.97±68, 251.77±78 and 252.89±82 for PLT values, respectively (P=0.033). The MPV and PLT values were not statistically significant in postprostatectomy ED patients and in control groups (P=0.663). There was no significant difference among the three groups in terms of white blood cells and hemoglobin levels. PLT count and mean PLT volume were detected to be increased in patients with vasculogenic ED. This finding may suggest a role for PLT volume in the pathogenesis of vasculogenic ED.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
National Institute of Health Consensus Development Panel on Impotence. Proceedings of a Conference held December 7–9, 1992, Bethesda. Maryland. JAMA 1993; 270: 83–90.
Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB . Incidence of erectile dysfunction in men 40-69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000; 163: 460–463.
Simonsen U, Garcia-Sacristan A, Prieto D . Penile arteries and erection. J Vasc Res 2002; 39: 283–303.
Tal R, Voelzke BB, Land S, Motarjem P, Munarriz R, Goldstein I et al. Vasculogenic erectile dysfunction in teenagers: a 5-year multi-institutional experience. BJU Int 2009; 103: 646–650.
Dong JY, Zhang YH, Qin LQ . Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol 2011; 58: 1378–1385.
Kamath S, Blann AD, Lip GY . Platelet activation: assessment and quantification. Eur Heart J 2001; 22: 1561–1571.
Yaşar AS, Bilen E, Yüksel IO, Arslantaş U, Karakaş F, Kirbaş O et al. Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction. Turk Kardiyol Dern Ars 2010; 38: 85–89.
Nadar S, Blann AD, Lip GY . Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipinebased antihypertensive therapy. Ann Med 2004; 36: 552–557.
Coban E, Ozdogan M, Yazicioglu G, Akcit F . The mean platelet volume in patients with obesity. Int J Clin Pract 2005; 59: 981–982.
Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010; 8: 148–156.
Mehta A, Miner M, Sigman M . Assessment of EndoPAT Scores in men with vasculogenic and non-vasculogenic erectile dysfunction. Int J Clin Pract 2013; 67: 46–51.
Vlachopoulos C, Ioakeimidis N, Terentes-Printzios D, Stefanadis C . The triad: erectile dysfunction—endothelial dysfunction—cardiovascular disease. Curr Pharm Des 2008; 14: 3700–3714.
Vlachopoulos C, Rokkas K, Ioakeimidis N, Stefanadis C . Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links. Eur Urol 2007; 52: 1590–1600.
Uslu N, Eren M, Gorgulu S, Alper AT, Orhan AL, Yildirim A et al. Left ventricular diastolic function and endothelial function in patients with erectile dysfunction. Am J Cardiol 2006; 97: 1785–1788.
Azadzoi KM, Master TA, Siroky MB . Effect of chronic ischemia on constitutive and inducible nitric oxide synthase expression in erectile tissue. J Androl 2004; 25: 382–388.
Solomon H, Man JW, Jackson G . Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003; 89: 251–253.
Inman BA, Sauver JL, Jacobson DJ, McGree ME, Nehra A, Lieber MM et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009; 84: 108–113.
Corona G, Rastrelli G, Monami M, Guay A, Buvat J, Sforza A et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol 2011; 165: 687–701.
Mittawae B, El-Nashaar AR, Fouda A, Magdy M, Shamloul R . Incidence of erectile dysfunction in 800 hypertensive patients: a multicenter Egyptian national study. Urology 2006; 67: 575–578.
Montorsi P, Montorsi F, Schulman CC . Is erectile dysfunction the “tip of the iceberg” of a systemic vascular disorder? Eur Urol 2003; 44: 352–354.
Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004; 103: 2096–2104.
Boos CJ, Balakrishnan B, Lip GY . The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood. J Thromb Thrombolysis 2008; 25: 135–140.
Khandekar MM, Khurana AS, Deshmukh SD, Kakrani AL, Katdare AD, Inamdar AK . Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario. J Clin Pathol 2006; 59: 146–149.
Bozkurt Y, Soylemez H, Sancaktutar AA, Islamoglu Y, Kar A, Penbegul N et al. Relationship between mean platelet volume and varicocele: a preliminary study. Urology 2012; 79: 1048–1051.
Yang A, Pizzulli L, Luderitz B . Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris. Thromb Res 2006; 117: 371–377.
Stokes KY, Granger DN . Platelets: A critical link between inflammationand microvascular dysfunction. J Physiol 2011; 590 (Pt 5): 1023–1034.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Ciftci, H., Gumuş, K., Yagmur, İ. et al. Assessment of Mean Platelet Volume in men with vasculogenic and nonvasculogenic erectile dysfunction. Int J Impot Res 27, 38–40 (2015). https://doi.org/10.1038/ijir.2014.17
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijir.2014.17
This article is cited by
-
Mean platelet volume as a predictive marker of erectile dysfunction: a meta-analysis
International Journal of Impotence Research (2022)
-
Ruolo del volume piastrinico medio nella disfunzione erettile a patogenesi arteriosa
L'Endocrinologo (2021)
-
Current Understanding of Vascular Wall Pathophysiology in Erectile Dysfunction and Priapism
SN Comprehensive Clinical Medicine (2020)
-
Efficacy and safety of combination of tadalafil and aspirin versus tadalafil or aspirin alone in patients with vascular erectile dysfunction: a comparative randomized prospective study
International Urology and Nephrology (2019)
-
Antiplatelet (aspirin) therapy as a new option in the treatment of vasculogenic erectile dysfunction: a prospective randomized double-blind placebo-controlled study
International Urology and Nephrology (2018)